Health System

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

FDA is expected to recommend a plan on distribution of COVID-19 booster shots to immunocompromised Americans; California becomes the first state to issue a vaccine mandate for its health care workers; exploring the threat of COVID-19 infection in pediatric populations.

Taiwanese patients with uveitis were shown to be at greater risk of developing psoriasis and psoriatic arthritis than the general population, and hypertension, diabetes, and obesity were more prominent in these populations as well.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

Using artificial intelligence (AI) effectively may help to revolutionize the diagnosis, monitoring, and treatment of multiple sclerosis (MS), as well as optimizing understanding of the immune-mediated disease.

The combined toll of the COVID-19 pandemic and the health effects of climate change tests an already beleaguered US health system.

Identifying patients with combined polypharmacy and frailty can help recognize ICU patients with high risk of hospital readmission, the authors said.

People with high risk of obstructive sleep apnea presented with significant changes in key arteries indicative of accelerated vascular aging, a known contributor to cardiovascular disease (CVD).

A significant risk of neurodegenerative disease was found in an analysis of male former professional soccer players, with defensive outfield players and those with careers longer than 15 years particularly at risk.

The study was conducted to shed more light on the growing issue of polypharmacy, an issue that is expected to increase as the US population ages.

Florida sets record for daily COVID-19 cases and hospitalizations; spotlighting health equity in the workplace; delineating COVID-19 hotspots where masking is recommended.

On World Lung Cancer Day, we explore current guidelines for lung cancer screening in the United States, implications of the COVID-19 pandemic, and disparities in mortality and access to care by race and socioeconomic status.

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, discusses the process of cataract development and its prevalence in both older and younger populations.

An overview of the latest news in Parkinson disease reported across MJH Life Sciences™.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Michael Thorpy, MD, director, Sleep-Wake Disorders Center, Montefiore, and professor, Neurology, Albert Einstein College of Medicine, speaks about common misconceptions within the treatment of narcolepsy-related excessive daytime sleepiness, and how combination therapy may play a role.

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

The Department of Justice (DOJ) and HHS issue joint guidance indicating that long COVID-19 can be classified as a disability; the Department of Veterans Affairs (VA) becomes the first federal agency to implement a COVID-19 vaccination mandate for some workers; federal regulators push for expansion of COVID-19 vaccine trials in children to better assess safety.

With nearly all parts of the country seeing a steady increase in COVID-19 infection, health care and medical groups are calling for mandatory vaccinations of their staff, and on Monday, the Department of Veterans Affairs, New York City, and California also announced vaccine requirements for workers.

Links between COVID-19 brain fog and risk of Alzheimer disease; cigarette manufacturer Philip Morris International discusses plans to stop selling cigarettes in the United Kingdom; COVID-19 vaccine adverse effects are more likely in people previously infected with the virus.

About 4 in 10 patients with chronic kidney disease will have “early rapid decline,” a trajectory more likely if the patient also has diabetes.

While polypharmacy, along with hospital length of stay and other factors, was linked to a higher risk of 30-day hospital readmission, the type of medication mattered as well.

Many respiratory viruses demonstrated atypical activity levels as compared with previous rates of activity during pre-pandemic seasonality, the CDC said this week.

Anne Marie Morse, DO, pediatric neurologist and sleep medicine specialist, Geisenger, speaks on early data findings of the Wake Up and Learn program which suggested a greater risk of sleep pathology among adolescents than typically observed.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.